Literature DB >> 20614996

Imaging targeted-agent binding in vivo with two probes.

Brian W Pogue, Kimberley S Samkoe, Shannon Hextrum, Julia A O'Hara, Michael Jermyn, Subhadra Srinivasan, Tayyaba Hasan.   

Abstract

An approach to quantitatively image targeted-agent binding rate in vivo is demonstrated with dual-probe injection of both targeted and nontargeted fluorescent dyes. Images of a binding rate constant are created that reveal lower than expected uptake of epidermal growth factor in an orthotopic xenograft pancreas tumor (2.3 x 10(-5) s(-1)), as compared to the normal pancreas (3.4 x 10(-5) s(-1)). This approach allows noninvasive assessment of tumor receptor targeting in vivo to determine the expected contrast, spatial localization, and efficacy in therapeutic agent delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20614996      PMCID: PMC2909298          DOI: 10.1117/1.3449109

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  7 in total

Review 1.  Monoclonal antibody therapy of cancer.

Authors:  Gregory P Adams; Louis M Weiner
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 2.  Early detection markers in Pancreas Cancer.

Authors:  James J Farrell; Marius van Rijnsoever; Hany Elsaleh
Journal:  Cancer Biomark       Date:  2005       Impact factor: 4.388

3.  Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro.

Authors:  Alan J Durkin; P Mark Bloomston; Alexander S Rosemurgy; Natalie Giarelli; Diane Cojita; Timothy J Yeatman; Emmanuel E Zervos
Journal:  Am J Surg       Date:  2003-11       Impact factor: 2.565

4.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging.

Authors:  Derek W Bartlett; Helen Su; Isabel J Hildebrandt; Wolfgang A Weber; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

Review 5.  Passive tumor targeting of soluble macromolecules and drug conjugates.

Authors:  L W Seymour
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1992       Impact factor: 4.889

Review 6.  Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.

Authors:  Philip A Philip; Margaret Mooney; Deborah Jaffe; Gail Eckhardt; Malcolm Moore; Neal Meropol; Leisha Emens; Eileen O'Reilly; Murray Korc; Lee Ellis; Jacqueline Benedetti; Mace Rothenberg; Christopher Willett; Margaret Tempero; Andrew Lowy; James Abbruzzese; Diane Simeone; Sunil Hingorani; Jordan Berlin; Joel Tepper
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

Review 7.  HER2/neu in systemic therapy for women with breast cancer: a systematic review.

Authors:  Bindi Dhesy-Thind; Kathleen I Pritchard; Hans Messersmith; Frances O'Malley; Leela Elavathil; Maureen Trudeau
Journal:  Breast Cancer Res Treat       Date:  2007-07-17       Impact factor: 4.872

  7 in total
  29 in total

Review 1.  Implicit and explicit prior information in near-infrared spectral imaging: accuracy, quantification and diagnostic value.

Authors:  Brian W Pogue; Scott C Davis; Frederic Leblond; Michael A Mastanduno; Hamid Dehghani; Keith D Paulsen
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

2.  Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Authors:  Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

3.  Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.

Authors:  Stephen C Kanick; Kenneth M Tichauer; Jason Gunn; Kimberley S Samkoe; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2014-08-29       Impact factor: 3.732

4.  Dual-tracer background subtraction approach for fluorescent molecular tomography.

Authors:  Kenneth M Tichauer; Robert W Holt; Fadi El-Ghussein; Scott C Davis; Kimberley S Samkoe; Jason R Gunn; Frederic Leblond; Brian W Pogue
Journal:  J Biomed Opt       Date:  2013-01       Impact factor: 3.170

5.  Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging.

Authors:  Kenneth M Tichauer; Kimberley S Samkoe; Kristian J Sexton; Jason R Gunn; Tayyaba Hasan; Brian W Pogue
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

6.  In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging.

Authors:  Kenneth M Tichauer; Kimberley S Samkoe; Kristian J Sexton; Shannon K Hextrum; Harold H Yang; W Spencer Klubben; Jason R Gunn; Tayyaba Hasan; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

7.  Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.

Authors:  K M Tichauer; K S Samkoe; W S Klubben; T Hasan; B W Pogue
Journal:  Phys Med Biol       Date:  2012-10-01       Impact factor: 3.609

8.  Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging.

Authors:  Kenneth M Tichauer; Sophie J Deharvengt; Kimberley S Samkoe; Jason R Gunn; Marcus W Bosenberg; Mary-Jo Turk; Tayyaba Hasan; Radu V Stan; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2013-11-12       Impact factor: 3.488

9.  Surgical Guidance via Multiplexed Molecular Imaging of Fresh Tissues Labeled with SERS-Coded Nanoparticles.

Authors:  Yu Wang; Soyoung Kang; Josh D Doerksen; Adam K Glaser; Jonathan T C Liu
Journal:  IEEE J Sel Top Quantum Electron       Date:  2016-03-21       Impact factor: 4.544

10.  Direct characterization of arterial input functions by fluorescence imaging of exposed carotid artery to facilitate kinetic analysis.

Authors:  Jonathan T Elliott; Kenneth M Tichauer; Kimberley S Samkoe; Jason R Gunn; Kristian J Sexton; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.